Structural basis for imipenem inhibition of class C β-lactamases

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 3978-3980

  Beadle, Beth M ^a   Shoichet, Brian K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE C; BETA LACTAMASE INHIBITOR; IMIPENEM; LATAMOXEF; UNCLASSIFIED DRUG; AMPC BETA LACTAMASES; AMPC BETA-LACTAMASES; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE TEM 1; BETA-LACTAMASE TEM-1;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DRUG BINDING; DRUG CONFORMATION; DRUG STRUCTURE; ELECTRIC CONDUCTIVITY; ENZYME BINDING; ENZYME INHIBITION; ESCHERICHIA COLI; HYDROLYSIS; NONHUMAN; OPTICAL RESOLUTION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; X RAY ANALYSIS; DRUG ANTAGONISM; DRUG EFFECT; X RAY CRYSTALLOGRAPHY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CRYSTALLOGRAPHY, X-RAY; IMIPENEM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036894235     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.3978-3980.2002     Document Type: Article

References (17)

1. Beadle, B. M., S. L. McGovern, A. Patera, and B. K. Shoichet. 1999. Functional analyses of AmpC beta-lactamase through differential stability. Protein Sci. 8:1816-1824.
2. Brunger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J. S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, R. J. Read, L. M. Rice, T. Simonson, and G. L. Warren. 1998. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr, Sect. D Biol. Crystallogr. 54:905-921.
3. Crichlow, G. V., M. Nukaga, V. R. Doppalapudi, J. D. Buynak, and J. R. Knox. 2001. Inhibition of class C beta-lactamases: Structure of a reaction intermediate with a cephem sulfone. Biochemistry 40:6233-6239.
4. Evans, S. V. 1993. SETOR: Hardware-lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11:127-128, 134-138.
5. Ferrin, T. E., C. C. Huang, L. E. Jarvis, and R. Langridge. 1988. The MIDAS display system. J. Mol. Graph. 6:13-27.
6. Fonze, E., M. Vanhove, G. Dive, E. Sauvage, J. M. Frere, and P. Charlier. 2002. Crystal structures of the Bacillus licheniformis BS3 class A beta-lactamase and of the acyl-enzyme adduct formed with cefoxitin. Biochemistry 41:1877-1885.
7. Jones, T. A., J. Y. Zou, S. W. Cowan, and Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47:110-119.
8. Lobkovsky, E., E. M. Billings, P. C. Moews, J. Rahil, R. F. Pratt, and J. R. Knox. 1994. Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: Mechanistic interpretation of a beta-lactamase transition-state analog. Biochemistry 33:6762-6772.
9. Matagne, A., J. Lamotte-Brasseur, G. Dive, J. R. Knox, and J. M. Frere. 1993. Interactions between active-site-serine beta-lactamases and compounds bearing a methoxy side chain on the alpha-face of the beta-lactam ring: Kinetic and molecular modelling studies. Biochem. J. 293:607-611.
10. Maveyraud, L., L. Mourey, L. P. Kotra, J. Pedelacq, V. Guillet, S. Mobashery, and J. Samama. 1998. Structural basis for clinical longevity of carbapenem antibiotics in the face of challenge by the common class A beta-lactamases from the antibiotic-resistant bacteria. J. Am. Chem. Soc. 120: 9748-9752.
11. Murphy, B. P., and R. F. Pratt. 1988. Evidence for an oxyanion hole in serine beta-lactamases and DD-peptidases. Biochem. J. 256:669-672.
12. Oefner, C., A. D'Arcy, J. J. Daly, K. Gubernator, R. L. Charnas, I. Heinze, C. Hubschwerlen, and F. K. Winkler. 1990. Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis. Nature 343:284-288.
13. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
14. Patera, A., L. C. Blaszczak, and B. K. Shoichet. 2000. Crystal structures of substrate and inhibitor complexes with AmpC beta-lactamase: Possible implications for substrate-assisted catalysis. J. Am. Chem. Soc. 122:10504-10512.
15. Powers, R. A., and B. K. Shoichet. 2002. Structure-based approach for binding site identification on AmpC beta-lactamase. J. Med. Chem. 32:3222-3234.
16. Usher, K. C., L. C. Blaszczak, G. S. Weston, B. K. Shoichet, and S. J. Remington. 1998. Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: Possible implications for the oxyanion hypothesis and for inhibitor design. Biochemistry. 37:16082-16092.
17. Wang, X., G. Minasov, and B. K. Shoichet. 2002. Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams. Proteins Struct. Funct. Genet. 47:86-96.